المؤلفون: Petit C., Lacas B., Pignon J. -P., Le Q. T., Gregoire V., Grau C., Hackshaw A., Zackrisson B., Parmar M. K. B., Lee J. -W., Ghi M. G., Sanguineti G., Temam S., Cheugoua-Zanetsie M., O'Sullivan B., Posner M. R., Vokes E. E., Cruz Hernandez J. J., Szutkowski Z., Lartigau E., Budach V., Suwinski R., Poulsen M., Kumar S., Ghosh Laskar S., Mazeron J. -J., Jeremic B., Simes R. J., Zhong L. -P., Overgaard J., Fortpied C., Torres-Saavedra P., Bourhis J., Auperin A., Blanchard P., Adelstein D. J., Agarwal J., Alfonsi M., Argiris A., Bacigalupo A., Bar-Ad V., Bartelink H., Beadle B., Belkacemi Y., Bensadoun R. J., Bernier J., Bratland A., Brizel D., Budach W., Burtness B., Calais G., Campbell B., Caudell J., Chabaud S., Chamorey E., Chaukar D., Cho K. H., Choussy O., Denham J. W., Dobrowsky W., Dominello M. M., Driessen C. M. L., Fallai C., Forastiere A. A., Fountzilas G., Garaud P., Garden A. S., Gery B., Ghadjar P., Graff-Cailleaud P., Haddad E., Haffty B. G., Hansen A., Hay J. H., Hayoz S., Horiot J. C., Hitt R., Johansen J., Jones C., Julieron M., Kristensen C. A., Langendijk J. A., Lapeyre M., Licitra L., Lee J. W., Lee P., Lewin F., Li Y., Lopes A., Lotayef M., Maciejewski B., Mazeron J. J., Mehta S., Michalski W., Moon J., Moon S. H., Moyal E., Nankivell M., Nilsson P., Olmi P., Orecchia R., Pignon J. P., Pointreau Y., Poulsen M. G., Quon H., Racadot S., Rosenthal D. I., Rovea P., Ruo Redda M. G., Shenouda G., Sharma A., Simon C., Sire C., Skladowski K., Spencer S., Staar S., Strojan P., Stromberger C., Takacsi-Nagy Z., Tao Y. G., Thomson D., Tobias J. S., Torri V., Tripcony L., Trotti A., Tseroni V., van Herpen C., van Tinteren H., Vermorken J., Viegas C. M. P., Waldron J., Wernecke K. D., Widder J., Wolf G. T., Wong S. J., Wu J. S., Yamazaki H., Zaktonik B.

المساهمون: Petit C., Lacas B., Pignon J.-P., Le Q.T., Gregoire V., Grau C., Hackshaw A., Zackrisson B., Parmar M.K.B., Lee J.-W., Ghi M.G., Sanguineti G., Temam S., Cheugoua-Zanetsie M., O'Sullivan B., Posner M.R., Vokes E.E., Cruz Hernandez J.J., Szutkowski Z., Lartigau E., Budach V., Suwinski R., Poulsen M., Kumar S., Ghosh Laskar S., Mazeron J.-J., Jeremic B., Simes R.J., Zhong L.-P., Overgaard J., Fortpied C., Torres-Saavedra P., Bourhis J., Auperin A., Blanchard P., Adelstein D.J., Agarwal J., Alfonsi M., Argiris A., Bacigalupo A., Bar-Ad V., Bartelink H., Beadle B., Belkacemi Y., Bensadoun R.J., Bernier J., Bratland A., Brizel D., Budach W., Burtness B., Calais G., Campbell B., Caudell J., Chabaud S., Chamorey E., Chaukar D., Cho K.H., Choussy O., Denham J.W., Dobrowsky W., Dominello M.M., Driessen C.M.L., Fallai C., Forastiere A.A., Fountzilas G., Garaud P., Garden A.S., Gery B., Ghadjar P., Graff-Cailleaud P., Haddad E., Haffty B.G., Hansen A., Hay J.H., Hayoz S., Horiot J.C., Hitt R., Johansen J., Jones C., Julieron M., Kristensen C.A., Langendijk J.A., Lapeyre M., Licitra L.

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33862002; info:eu-repo/semantics/altIdentifier/wos/WOS:000686283200038; volume:22; issue:5; firstpage:727; lastpage:736; numberofpages:10; journal:THE LANCET ONCOLOGY; https://hdl.handle.net/2318/1893712Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85105832610

الإتاحة: https://doi.org/10.1016/S1470-2045Test(21)00076-0
https://hdl.handle.net/2318/1893712Test

المؤلفون: Ledermann, J. A., Embleton-Thirsk, A. C., Perren, T. J., Jayson, G. C., Rustin, G. J. S., Kaye, S. B., Hirte, H., Oza, A., Vaughan, M., Friedlander, M., González-Martín, A., Deane, E., Popoola, B., Farrelly, L., Swart, A. M., Kaplan, R. S., Parmar, M. K. B.

وصف الملف: application/pdf

العلاقة: https://ueaeprints.uea.ac.uk/id/eprint/79569/1/Published_Version.pdfTest; Ledermann, J. A., Embleton-Thirsk, A. C., Perren, T. J., Jayson, G. C., Rustin, G. J. S., Kaye, S. B., Hirte, H., Oza, A., Vaughan, M., Friedlander, M., González-Martín, A., Deane, E., Popoola, B., Farrelly, L., Swart, A. M., Kaplan, R. S. and Parmar, M. K. B. and on behalf of the ICON6 collaborators (2021) Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial. ESMO Open, 6 (2). ISSN 2059-7029

الإتاحة: https://doi.org/10.1016/j.esmoop.2020.100043Test
https://ueaeprints.uea.ac.uk/id/eprint/79569Test/
https://ueaeprints.uea.ac.uk/id/eprint/79569/1/Published_Version.pdfTest

المؤلفون: Seckl, M., Ghorani, E., Quartagno, M., Blackhall, Fiona H, Gilbert, D. C., O'Brien, M. E. R., Ottensmeier, C. H. H., Pizzo, E., Spicer, J. F., Williams, A., Badman, P. D., Parmar, M. K. B.

المساهمون: Imperial College London, London

العلاقة: https://dx.doi.org/10.1200/JCO.2023.41.16_suppl.TPS9145Test; Seckl M, Ghorani E, Quartagno M, Blackhall FH, Gilbert DC, O'Brien MER, et al. REFINE-Lung: A multicentre phase III study to determine the optimal frequency of pembrolizumab in non-small cell lung cancer utilising a novel multi-arm design. Journal of Clinical Oncology. 2023 Jun;41(16). PubMed PMID: WOS:001053772005494.; http://hdl.handle.net/10541/626665Test; Journal of Clinical Oncology

الإتاحة: https://doi.org/10.1200/JCO.2023.41.16_suppl.TPS9145Test
http://hdl.handle.net/10541/626665Test

المؤلفون: Vale, C. L., Fisher, D. J., Godolphin, P. J., Rydzewska, L. H., Boher, J. M., Burdett, S., Chen, Y. H., Clarke, Noel W, Fizazi, K., Gravis, G., James, N. D., Liu, G., Matheson, D., Murphy, L., Oldroyd, R. E., Parmar, M. K. B., Rogozinska, E., Sfumato, P., Sweeney, C. J., Sydes, M. R., Tombal, B., White, I. R., Tierney, J. F.

المساهمون: MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK

العلاقة: https://dx.doi.org/10.1016/s1470-2045Test(23)00230-9; Vale CL, Fisher DJ, Godolphin PJ, Rydzewska LH, Boher JM, Burdett S, et al. Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials. The Lancet Oncology. 2023 Jul;24(7):783-97. PubMed PMID: 37414011. Epub 2023/07/07. eng.; http://hdl.handle.net/10541/626442Test; Lancet Oncology

الإتاحة: https://doi.org/10.1016/s1470-2045Test(23)00230-9
http://hdl.handle.net/10541/626442Test

المؤلفون: Ghorani, E., Quartagno, M., Blackhall, Fiona H, Gilbert, D. C., O'Brien, M., Ottensmeier, C., Pizzo, E., Spicer, J., Williams, A., Badman, P., Parmar, M. K. B., Seckl, M. J.

المساهمون: Department of Medical Oncology, Charing Cross Gestational Trophoblastic Disease Centre, Charing Cross Hospital Campus of Imperial College London, London, UK

العلاقة: https://dx.doi.org/10.1016/s1470-2045Test(23)00095-5; Ghorani E, Quartagno M, Blackhall F, Gilbert DC, O'Brien M, Ottensmeier C, et al. REFINE-Lung implements a novel multi-arm randomised trial design to address possible immunotherapy overtreatment. The Lancet Oncology. 2023 May;24(5):e219-e27. PubMed PMID: 37142383. Epub 2023/05/05. eng.; http://hdl.handle.net/10541/626291Test; Lancet Oncology

الإتاحة: https://doi.org/10.1016/s1470-2045Test(23)00095-5
http://hdl.handle.net/10541/626291Test

المؤلفون: Attard, G., Murphy, L., Clarke, Noel W, Sachdeva, Ashwin, Jones, Craig, Hoyle, Alex, Cross, W., Jones, R. J., Parker, C. C., Gillessen, S., Cook, A., Brawley, C., Gilson, C., Rush, H., Abdel-Aty, H., Amos, C. L., Murphy, C., Chowdhury, S., Malik, Z., Russell, J. M., Parkar, N., Pugh, C., Diaz-Montana, C., Pezaro, C., Grant, W., Saxby, H., Pedley, I., O'Sullivan, J. M., Birtle, A., Gale, J., Srihari, N., Thomas, C., Tanguay, J., Wagstaff, J., Das, P., Gray, E., Alzouebi, M., Parikh, O., Robinson, A., Montazeri, A. H., Wylie, James P, Zarkar, A., Cathomas, R., Brown, Michael D, Jain, Yatin, Dearnaley, D. P., Mason, M. D., Gilbert, D., Langley, R. E., Millman, R., Matheson, D., Sydes, M. R., Brown, L. C., Parmar, M. K. B., James, N. D.

المساهمون: Cancer Institute, University College London, London, UK, University College London Hospitals, London, UK

العلاقة: https://dx.doi.org/10.1016/s1470-2045Test(23)00148-1; Attard G, Murphy L, Clarke NW, Sachdeva A, Jones C, Hoyle A, et al. Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol. The Lancet Oncology. 2023 May;24(5):443-56. PubMed PMID: 37142371. Epub 2023/05/05. eng.; http://hdl.handle.net/10541/626288Test; Lancet Oncology

الإتاحة: https://doi.org/10.1016/s1470-2045Test(23)00148-1
http://hdl.handle.net/10541/626288Test

المؤلفون: Clarke, N W, Ali, A, Ingleby, F C, Hoyle, A, Amos, C L, Attard, G, Brawley, C D, Calvert, J, Chowdhury, S, Cook, A, Cross, W, Dearnaley, D P, Douis, H, Gilbert, D, Gillessen, S, Jones, R.J., Langley, R E, MacNair, A, Malik, Z, Mason, M D, Matheson, D, Millman, R, Parker, C C, Ritchie, A W S, Rush, H, Russell, J M, Brown, J, Beesley, S, Birtle, A, Capaldi, L, Gale, J, Gibbs, S, Lydon, A, Nikapota, A, Omlin, A, O'Sullivan, J M, Parikh, O, Protheroe, A, Rudman, S, Srihari, N N, Simms, M, Tanguay, J S, Tolan, S, Wagstaff, J, Wallace, J, Wylie, J, Zarkar, A, Sydes, M R, Parmar, M K B, James, N D

وصف الملف: text

العلاقة: http://eprints.gla.ac.uk/199120/1/199120.pdfTest; Clarke, N. W. et al. (2019) Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial. Annals of Oncology , 30(123), pp. 1992-2003. (doi:10.1093/annonc/mdz396 ) (PMID:31560068) (PMCID:PMC6938598)

الإتاحة: https://doi.org/10.1093/annonc/mdz396Test
http://eprints.gla.ac.uk/199120Test/
http://eprints.gla.ac.uk/199120/1/199120.pdfTest

المؤلفون: Vale, C L, Fisher, D J, White, I R, Carpenter, J R, Burdett, S, Clarke, N W, Fizazi, K, Gravis, G, James, N D, Mason, Malcolm, Parmar, M K B, Rydzewska, L H, Sweeney, C J, Spears, M R, Sydes, M R, Tierney, J F

وصف الملف: application/pdf

العلاقة: https://orca.cardiff.ac.uk/id/eprint/112173/9/mdy071.pdfTest; Vale, C L, Fisher, D J, White, I R, Carpenter, J R, Burdett, S, Clarke, N W, Fizazi, K, Gravis, G, James, N D, Mason, Malcolm https://orca.cardiff.ac.uk/view/cardiffauthors/A008319Q.htmlTest orcid:0000-0003-1505-2869 orcid:0000-0003-1505-2869, Parmar, M K B, Rydzewska, L H, Sweeney, C J, Spears, M R, Sydes, M R and Tierney, J F 2018. What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis. Annals of Oncology 29 (5) , pp. 1249-1257. 10.1093/annonc/mdy071 https://doi.org/10.1093/annonc%2Fmdy071Test file https://orca.cardiff.ac.uk/id/eprint/112173/9/mdy071.pdfTest

الإتاحة: https://doi.org/10.1093/annonc/mdy071Test
https://orca.cardiff.ac.uk/id/eprint/112173Test/
https://orca.cardiff.ac.uk/id/eprint/112173/9/mdy071.pdfTest

المؤلفون: Grist, E., Friedrich, S., Brawley, C., Mendes, L., Parry, M., Ali, Adnan, Haran, Aine, Hoyle, Alex P, Gilson, C., Lall, S., Zakka, L., Bautista, C., Landless, A., Nowakowska, K., Wingate, A., Wetterskog, D., Hasan, A. M. M., Akato, N. B., Richmond, M., Ishaq, S., Matthews, N., Hamid, A. A., Sweeney, C. J., Sydes, M. R., Berney, D. M., Lise, S., Parmar, M. K. B., Clarke, Noel W, James, N. D., Cremaschi, P., Brown, L. C., Attard, G.

المساهمون: Cancer Institute, University College London, London, UK

العلاقة: https://dx.doi.org/10.1186/s13073-022-01080-4Test; Grist E, Friedrich S, Brawley C, Mendes L, Parry M, Ali A, et al. Accumulation of copy number alterations and clinical progression across advanced prostate cancer. Genome Med. 2022 Sep 5;14(1):102. PubMed PMID: 36059000. Pubmed Central PMCID: PMC9442998. Epub 2022/09/05. eng.; http://hdl.handle.net/10541/625612Test; Genome Medicine

الإتاحة: https://doi.org/10.1186/s13073-022-01080-4Test
http://hdl.handle.net/10541/625612Test

المؤلفون: James, N. D., Ingleby, F. C., Clarke, Noel W, Amos, C., Attard, G., Brawley, C. D., Chowdhury, S., Cross, W., Dearnaley, D. P., Gilbert, D. C., Gillessen, S., Jones, R. J., Langley, R. E., Macnair, A., Malik, Z. I., Mason, M. D., Matheson, D. J., Millman, R., Parker, C. C., Rush, H. L., Russell, J. M., Au, C., Ritchie, A. W. S., Mestre, R. P., Ahmed, I., Birtle, A. J., Brock, S. J., Das, P., Ford, V. A., Gray, E. K., Hughes, R. J., Manetta, C. B., McLaren, D. B., Nikapota, A. D., O'Sullivan, J. M., Perna, C., Peedell, C., Protheroe, A. S., Sundar, S., Tanguay, J. S., Tolan, S. P., Wagstaff, J., Wallace, J. B., Wylie, James P, Zarkar, A., Parmar, M. K. B., Sydes, M. R.

المساهمون: The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK

العلاقة: https://dx.doi.org/10.1093/jncics/pkac043Test; James ND, Ingleby FC, Clarke NW, Amos C, Attard G, Brawley CD, et al. Docetaxel for nonmetastatic prostate cancer: long-term survival outcomes in the STAMPEDE randomized controlled trial. JNCI cancer spectrum. 2022 Jul 25;6(4). PubMed PMID: 35877084. Epub 2022/07/26. eng.; http://hdl.handle.net/10541/625446Test; JNCI Cancer Spectrum

الإتاحة: https://doi.org/10.1093/jncics/pkac043Test
http://hdl.handle.net/10541/625446Test